Notification That Annual Report Will Be Submitted Late (nt 10-k)
01 4월 2023 - 6:17AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
12b-25
Commission
File Number 000-53754
NOTIFICATION
OF LATE FILING
(Check
One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR
For
Period Ended: December 31, 2022
☐ |
Transition
Report on Form 10-K |
☐ |
Transition
Report on Form 10-Q |
|
|
|
|
☐ |
Transition
Report on Form 20-F |
☐ |
Transition
Report on Form N-SAR |
|
|
|
|
☐ |
Transition
Report on Form 11-K |
|
|
For
Transition Period Ended: |
|
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the item(s) to which the
notification
relates:_______________________________________________________________ |
PART
I
REGISTRANT
INFORMATION
Full
name of registrant: VYCOR MEDICAL, INC.
Address
of principal executive office (Street and number): 951 Broken Sound Pkwy, Suite 320
Boca
Raton, FL 33487
PART
II
RULE
12-b 25 (b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate.)
☐
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒
(b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will
be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on
Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
☐
(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART
III
NARRATIVE
State
below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed
within the prescribed time period. (Attach extra sheets if needed.)
The
Registrant is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense due to the complexity
of certain of its operations. The Registrant anticipates that it will file its Form 10-K within the grace period provided by Exchange
Act Rule 12b-25.
PART
IV
OTHER
INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification: Adrian Liddell, Chief Financial Officer, Tel. (561) 558-2000.
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If the answer is no, identify report(s).
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
If
so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
|
VYCOR
MEDICAL, INC. |
|
|
(Name
of Registrant as Specified in Charter) |
|
Has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
|
VYCOR
MEDICAL, INC. |
|
|
|
|
By: |
/S/
Adrian Liddell |
|
|
Adrian
Liddell |
|
|
Chief
Financial Officer |
Date:
March 31, 2023
Vycor Medical (QB) (USOTC:VYCO)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Vycor Medical (QB) (USOTC:VYCO)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024